Episode 21. Newly Diagnosed Mantle Cell Lymphoma
Blood Cancer Talks
Next-Gen Sequencing for T-53 in Mantisol Lymphoma
The second-generation BDKIs are quite similar when it comes to efficacy, and that holds up for both alkalines and a-bruiting it. So, therefore, if I, with my knowledge, would be practicing in the US, this is exactly what I would do. Do you think every mental cell and inflammation should get next-generation sequencing for T-53 at diagnosis? Well, absolutely. It should be done, and why is that? In mantisol lymphoma specifically, rotation have a much stronger prognostic impact in comparison to deletion.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
